Anthracyclines, bendamustine are options for grade 3A follicular lymphomaFebruary 11, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
Ibrutinib-MTX-rituximab combo shows promise in CNS lymphomaFebruary 11, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
Applying ECHELON-2 results to clinical practiceJanuary 31, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
Novel bispecific CAR shows promise in B-cell malignanciesJanuary 25, 2019Aggressive LymphomasLymphoma & Plasma Cell DisordersTransplantation
Combo treatment may improve quality of life in CTCLJanuary 24, 2019Lymphoma & Plasma Cell DisordersAggressive Lymphomas
Are single agents better than chemo for relapsed/refractory PTCL?January 24, 2019Lymphoma & Plasma Cell DisordersAggressive Lymphomas
Four-drug combo shows durable responses in relapsed/refractory lymphomasJanuary 19, 2019Aggressive Lymphomas
Chidamide may be more effective in PTCL than previously thoughtJanuary 16, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
Group proposes new grading systems for CRS, neurotoxicityJanuary 3, 2019Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationALLNon-Hodgkin LymphomaAggressive Lymphomas
Risk of second cancers in Hodgkin lymphoma survivorsDecember 27, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
CHMP recommends BV+AVD for Hodgkin lymphomaDecember 18, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Combo bests standard care in younger CLL patientsDecember 12, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Mutation confers resistance to venetoclax in CLLDecember 7, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Two-drug combo deemed ‘very promising’ for PMBCLDecember 6, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Update shows durable responses in rel/ref DLBCLDecember 4, 2018Lymphoma & Plasma Cell DisordersAggressive Lymphomas
